155 related articles for article (PubMed ID: 24453831)
1. Von Willebrand factor antigen predicts response to double dose of aspirin and clopidogrel by PFA-100 in patients undergoing primary angioplasty for ST elevation myocardial infarction.
Gianetti J; Parri MS; Della Pina F; Marchi F; Koni E; De Caterina A; Maffei S; Berti S
ScientificWorldJournal; 2013; 2013():313492. PubMed ID: 24453831
[TBL] [Abstract][Full Text] [Related]
2. [Non ST elevation acute coronary syndrome. Some characteristics of coagulation and von Willebrand factor during short term use of ticlopidine or clopidogrel].
Averkov OV; Slavina NN; Gratsianskiĭ NA
Kardiologiia; 2003; 43(10):50-9. PubMed ID: 14593356
[TBL] [Abstract][Full Text] [Related]
3. Residual platelet reactivity after aspirin and clopidogrel treatment predicts 2-year major cardiovascular events in patients undergoing percutaneous coronary intervention.
Chiu FC; Wang TD; Lee JK; Shih FY; Lin JW; Huang CH; Chen WJ; Chen MF
Eur J Intern Med; 2011 Oct; 22(5):471-7. PubMed ID: 21925055
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between post-stenting coronary thrombolysis in myocardial infarction flow and plasma von Willebrand factor and ADAMTS-13 levels in patients with ST segment elevation myocardial infarction].
Zhou Q; Li J; Luo XP; Shi HM; Chen H; Zhao BL; Zhu J; Ni HC; Shen W; Wang CP
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):212-6. PubMed ID: 21609524
[TBL] [Abstract][Full Text] [Related]
5. Monitoring aspirin 100 mg and clopidogrel 75 mg therapy with the PFA-100 device in patients with peripheral arterial disease.
Mueller T; Haltmayer M; Poelz W; Haidinger D
Vasc Endovascular Surg; 2003; 37(2):117-23. PubMed ID: 12669143
[TBL] [Abstract][Full Text] [Related]
6. Relation between impaired antiplatelet response to clopidogrel and possible pleiotropic effects.
Malek LA; Grabowski M; Spiewak M; Filipiak KJ; Szpotanska M; Imiela T; Huczek Z; Bobilewicz D; Opolski G
J Thromb Thrombolysis; 2007 Dec; 24(3):301-5. PubMed ID: 17404690
[TBL] [Abstract][Full Text] [Related]
7. Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS.
Fuchs I; Frossard M; Spiel A; Riedmüller E; Laggner AN; Jilma B
J Thromb Haemost; 2006 Dec; 4(12):2547-52. PubMed ID: 17002662
[TBL] [Abstract][Full Text] [Related]
8. In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor.
Chakroun T; Gerotziafas G; Robert F; Lecrubier C; Samama MM; Hatmi M; Elalamy I
Br J Haematol; 2004 Jan; 124(1):80-5. PubMed ID: 14675411
[TBL] [Abstract][Full Text] [Related]
9. High post-clopidogrel platelet reactivity assessed by a point-of-care assay predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction who underwent primary coronary stenting.
Jin HY; Yang TH; Kim DI; Chung SR; Seo JS; Jang JS; Kim DK; Kim DK; Kim KH; Seol SH; Nam CW; Hur SH; Kim W; Park JS; Kim YJ; Kim DS
Int J Cardiol; 2013 Sep; 167(5):1877-81. PubMed ID: 22682702
[TBL] [Abstract][Full Text] [Related]
10. Clopidogrel-induced platelet inhibition cannot be detected by the platelet function analyzer-100 system in stroke patients.
Kotzailias N; Elwischger K; Sycha T; Rinner W; Quehenberger P; Auff E; Müller C
J Stroke Cerebrovasc Dis; 2007; 16(5):199-202. PubMed ID: 17845916
[TBL] [Abstract][Full Text] [Related]
11. High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.
Parodi G; Marcucci R; Valenti R; Gori AM; Migliorini A; Giusti B; Buonamici P; Gensini GF; Abbate R; Antoniucci D
JAMA; 2011 Sep; 306(11):1215-23. PubMed ID: 21934054
[TBL] [Abstract][Full Text] [Related]
12. Pantoprazole significantly interferes with antiplatelet effect of clopidogrel: results of a pilot randomized trial.
Parri MS; Gianetti J; Dushpanova A; Della Pina F; Saracini C; Marcucci R; Giusti B; Berti S
Int J Cardiol; 2013 Sep; 167(5):2177-81. PubMed ID: 22727972
[TBL] [Abstract][Full Text] [Related]
13. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.
Mehta SR; Yusuf S; Peters RJ; Bertrand ME; Lewis BS; Natarajan MK; Malmberg K; Rupprecht H; Zhao F; Chrolavicius S; Copland I; Fox KA;
Lancet; 2001 Aug; 358(9281):527-33. PubMed ID: 11520521
[TBL] [Abstract][Full Text] [Related]
14. Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation.
Van der Planken MG; Claeys MJ; Vertessen FJ; Dilling D; Bosmans JM; Berneman ZN; Michiels JJ; Vrints C
Thromb Res; 2003; 111(3):159-64. PubMed ID: 14678814
[TBL] [Abstract][Full Text] [Related]
15. Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.
Favaloro EJ; Facey D; Henniker A
Am J Hematol; 1999 Nov; 62(3):165-74. PubMed ID: 10539883
[TBL] [Abstract][Full Text] [Related]
16. Platelet function predicts myocardial damage in patients with acute myocardial infarction.
Frossard M; Fuchs I; Leitner JM; Hsieh K; Vlcek M; Losert H; Domanovits H; Schreiber W; Laggner AN; Jilma B
Circulation; 2004 Sep; 110(11):1392-7. PubMed ID: 15313953
[TBL] [Abstract][Full Text] [Related]
17. High on clopidogrel treatment platelet reactivity is frequent in acute and rare in elective stenting and can be functionally overcome by switch of therapy.
Leé S; Vargová K; Hizoh I; Horváth Z; Gulácsi-Bárdos P; Sztupinszki Z; Apró A; Kovács A; Préda I; Tóth-Zsámboki E; Kiss RG
Thromb Res; 2014 Feb; 133(2):257-64. PubMed ID: 24359966
[TBL] [Abstract][Full Text] [Related]
18. Single high-dose bolus tirofiban with high-loading-dose clopidogrel in primary coronary angioplasty.
Bilsel T; Akbulut T; Yesilcimen K; Terzi S; Sayar N; Dayi SU; Akgoz H; Ergelen M; Ciloglu F
Heart Vessels; 2006 Mar; 21(2):102-7. PubMed ID: 16550311
[TBL] [Abstract][Full Text] [Related]
19. Utility of the PFA-100 instrument and the novel multiplate analyzer for the assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular disease.
Mueller T; Dieplinger B; Poelz W; Haltmayer M
Clin Appl Thromb Hemost; 2009 Dec; 15(6):652-9. PubMed ID: 18805846
[TBL] [Abstract][Full Text] [Related]
20. Platelet inhibition by adjunctive cilostazol versus high maintenance-dose clopidogrel in patients with acute myocardial infarction according to cytochrome P450 2C19 genotype.
Kim IS; Jeong YH; Park Y; Park KS; Yun SE; Park JR; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S
JACC Cardiovasc Interv; 2011 Apr; 4(4):381-91. PubMed ID: 21511217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
